Hematopoietic stem cell gene therapy for adenosine deaminase deficient-SCID

被引：23
|
作者：
Aiuti, Alessandro [1 ,2 ,3 ]
Brigida, Immacolata [1 ,2 ]
Ferrua, Francesca [1 ,2 ]
Cappelli, Barbara [1 ,2 ]
Chiesa, Robert [1 ,2 ]
Marktel, Sarah [1 ,2 ]
Roncarolo, Maria-Grazia [1 ,2 ,4 ]
机构：
[1] Sci Inst HS Raffaele, San Raffaele Telethon Inst Gene Therapy HSR TIGET, I-20132 Milan, Italy
[2] Sci Inst HS Raffaele, Pediat Immunohematol & Bone Marrow Transplant Uni, I-20132 Milan, Italy
[3] Univ Roma Tor Vergata, Rome, Italy
[4] Univ Vita Salute, Milan, Italy
来源：
IMMUNOLOGIC RESEARCH | 2009年 / 44卷 / 1-3期
关键词：
Gene therapy; Hematopoietic stem cell; Bone marrow; Severe combined immunodeficiency; Retroviral vector; SEVERE COMBINED IMMUNODEFICIENCY; BONE-MARROW-TRANSPLANTATION; INSERTIONAL MUTAGENESIS; CD34(+) CELLS; CORD BLOOD; IMMUNE RECONSTITUTION; LENTIVIRAL VECTORS; MOUSE MODEL; ADA; LYMPHOCYTES;
D O I：
10.1007/s12026-009-8107-8
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Gene therapy is a highly attractive strategy for many types of inherited disorders of the immune system. Adenosine deaminase (ADA) deficient-severe combined immunodeficiency (SCID) has been the target of several clinical trials based on the use of hematopoietic stem/progenitor cells engineered with retroviral vectors. The introduction of a low intensity conditioning regimen has been a crucial factor in achieving stable engrafment of hematopoietic stem cells and therapeutic levels of ADA-expressing cells. Recent studies have demonstrated that gene therapy for ADA-SCID has favorable safety profile and is effective in restoring normal purine metabolism and immune functions. Stem cell gene therapy combined with appropriate conditioning regimens might be extended to other genetic disorders of the hematopoietic system.
引用
收藏
页码：150 / 159
页数：10
相关论文
共 50 条
  • [31] Successful engraftment of haploidentical stem cell transplant with post-transplantation cyclophosphamide in a patient with adenosine deaminase deficiency
    Medina, Diego
    Aristizabal, Ana M.
    Madronero, Tatiana
    Perez, Paola
    Patino Nino, Jaime
    Olaya, Manuela
    PEDIATRIC TRANSPLANTATION, 2021, 25 (06)
  • [32] Successful Preclinical Development of Gene Therapy for Recombinase-Activating Gene-1-Deficient SCID
    Garcia-Perez, Laura
    van Eggermond, Marja
    van Roon, Lieke
    Vloemans, Sandra A.
    Cordes, Martijn
    Schambach, Axel
    Rothe, Michael
    Berghuis, Dagmar
    Lagresle-Peyrou, Chantal
    Cavazzana, Marina
    Zhang, Fang
    Thrasher, Adrian J.
    Salvatori, Daniela
    Meij, Pauline
    Villa, Anna
    Van Dongen, Jacques J. M.
    Zwaginga, Jaap-Jan
    van der Burg, Mirjam
    Gaspar, H. Bobby
    Lankester, Arjan
    Staal, Frank J. T.
    Pike-Overzet, Karin
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2020, 17 : 666 - 682
  • [33] Development of gene therapy: potential in severe combined immunodeficiency due to adenosine deaminase deficiency
    Montiel-Equihua, Claudia A.
    Thrasher, Adrian J.
    Gaspar, H. Bobby
    STEM CELLS AND CLONING-ADVANCES AND APPLICATIONS, 2010, 3 : 1 - 12
  • [34] Lentiviral Hematopoietic Stem Cell Gene Therapy Benefits Metachromatic Leukodystrophy
    Biffi, Alessandra
    Montini, Eugenio
    Lorioli, Laura
    Cesani, Martina
    Fumagalli, Francesca
    Plati, Tiziana
    Baldoli, Cristina
    Martino, Sabata
    Calabria, Andrea
    Canale, Sabrina
    Benedicenti, Fabrizio
    Vallanti, Giuliana
    Biasco, Luca
    Leo, Simone
    Kabbara, Nabil
    Zanetti, Gianluigi
    Rizzo, William B.
    Mehta, Nalini A. L.
    Cicalese, Maria Pia
    Casiraghi, Miriam
    Boelens, Jaap J.
    Del Carro, Ubaldo
    Dow, David J.
    Schmidt, Manfred
    Assanelli, Andrea
    Neduva, Victor
    Di Serio, Clelia
    Stupka, Elia
    Gardner, Jason
    von Kalle, Christof
    Bordignon, Claudio
    Ciceri, Fabio
    Rovelli, Attilio
    Roncarolo, Maria Grazia
    Aiuti, Alessandro
    Sessa, Maria
    Naldini, Luigi
    SCIENCE, 2013, 341 (6148) : 864 - U58
  • [35] Historical Perspective on the Current Renaissance for Hematopoietic Stem Cell Gene Therapy
    Kohn, Donald B.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2017, 31 (05) : 721 - +
  • [36] Hematopoietic Stem Cell Gene Therapy
    David W. Emery
    Tamon Nishino
    Ken Murata
    Michalis Fragkos
    George Stamatoyannopoulos
    International Journal of Hematology, 2002, 75 : 228 - 236
  • [37] Hematopoietic stem cell gene therapy
    Emery, DW
    Nishino, T
    Murata, K
    Fragkos, M
    Stamatoyannopoulos, G
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2002, 75 (03) : 228 - 236
  • [38] Hematopoietic stem cell gene therapy to halt neurodegeneration
    Biffi, Alessandra
    NEUROTHERAPEUTICS, 2024, 21 (04)
  • [39] Genetic engineering meets hematopoietic stem cell biology for next-generation gene therapy
    Ferrari, Samuele
    Valeri, Erika
    Conti, Anastasia
    Scala, Serena
    Aprile, Annamaria
    Di Micco, Raffaella
    Kajaste-Rudnitski, Anna
    Montini, Eugenio
    Ferrari, Giuliana
    Aiuti, Alessandro
    Naldini, Luigi
    CELL STEM CELL, 2023, 30 (05) : 549 - 570
  • [40] A 24-Year Enzyme Replacement Therapy in an Adenosine-deaminase-Deficient Patient
    Tartibi, Hana M.
    Hershfield, Michael S.
    Bahna, Sami L.
    PEDIATRICS, 2016, 137 (01)
12345